R01MH131551

Neuroimaging Cholinergic Mechanisms of Fear Extinction in PTSD - Project Summary

Post-Traumatic Stress Disorder (PTSD) is a deeply debilitating disorder with severe public health burden. Yet, current pharmacological treatments are glaringly suboptimal. The A7 Nicotinic Acetylcholine Receptor (nAChR) is a salient molecular target for PTSD therapeutics. Acetylcholine regulates fear learning and memory processes that are impaired in people with PTSD, and A7 nAChR density is reduced by chronic stress in preclinical models.

Despite this compelling evidence, the role of A7 nAChRs in the pathophysiology of PTSD in humans is not fully understood. To address this gap, this proposal will characterize A7 nAChR contributions to behavioral and neural markers of fear learning in trauma-exposed participants representing the full spectrum of PTSD severity.

Using [18F]ASEM, a Positron Emission Tomography (PET) radioligand specific to A7 nAChRs, we obtained exciting preliminary data indicating lower A7 nAChR availability in people with PTSD that is associated with the severity of PTSD symptom clusters. Further, lower A7 nAChR availability in amygdala corresponded to weakened functional connectivity of the amygdala and ventromedial prefrontal cortex, which is a key circuit that underpins fear learning processes.

Motivated by these exciting data, the primary objective of this project is to characterize A7 nAChR contributions to fear extinction learning and circuitry in PTSD. To achieve this goal, we will recruit 80 participants with trauma exposure sampled across the full dimensional spectrum of PTSD symptoms. All participants will be scanned with [18F]ASEM PET and participate in an established fear reversal task with concurrent functional magnetic resonance imaging (fMRI).

The acquired data will be used to address three specific aims. Aim 1 will determine if people with PTSD have lower A7 nAChR availability than trauma-exposed controls, and which PTSD symptom cluster severities correspond to lower A7 nAChR availability. Aim 2 will determine if lower A7 nAChR availability in amygdala predicts impaired learning rates during fear extinction. Aim 3 will determine if lower A7 nAChR availability in amygdala predicts weaker VMPFC-amygdala connectivity during fear extinction.

A final analysis will determine if amygdala A7 nAChR availability mediates the relationship of amygdala-VMPFC connectivity with fear extinction learning rates, assessing these receptors as a mechanism underlying disrupted fear extinction circuits in PTSD.

The findings will determine A7 nAChR roles in the pathophysiology of fear extinction and its brain circuits in living people, informing future therapeutic development to address fear extinction impairments that underlie chronic PTSD symptoms.

Regents Of The University Of Michigan

NOT APPLICABLE

93.242 - Mental Health Research Grants

National Institute of Mental Health (NIMH) [HHS - NIH]

Ann Arbor, Michigan 481082744 United States

Single Zip Code

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-20-185)

Amendment Since initial award the total obligations have increased 280% from $835,523 to $3,177,685.